All Stories

  1. Loss of serotonergic function in carriers of PRKN mutations: a [11C]DASB PET study
  2. Long-Term Prognostic Value in Nuclear Cardiology: Expert Scoring Combined with Automated Measurements vs. Angiographic Score
  3. Long-Term Prognostic Value of Automated Measurements in Nuclear Cardiology: Comparisons with Expert Scoring
  4. Investigating the genetic characteristics of CAD: Is there a role for myocardial perfusion imaging techniques?
  5. Automated Analysis vs. Expert Reading in Nuclear Cardiology: Correlations with the Angiographic Score
  6. Anosognosia in Dementia: Evaluation of Perfusion Correlates Using 99mTc-HMPAO SPECT and Automated Brodmann Areas Analysis
  7. Τhe Greek Variant in APP Gene: The Phenotypic Spectrum of APP Mutations
  8. Correlation of Neuropsychiatric Symptoms in Dementia with Brain Perfusion: A 99mTc-SPECT-HMPAO Study with Brodmann Areas Analysis
  9. α‐Synuclein (SNCA) A30G Mutation as a Cause of a Complex Phenotype Without Parkinsonism
  10. From courage to ischaemia: is still there a role for myocardial perfusion imaging (MPI) in stable coronary artery disease?
  11. Eating Disorders in Frontotemporal Dementia and Alzheimer’s Disease: Evaluation of Brain Perfusion Correlates Using 99mTc-HMPAO SPECT with Brodmann Areas Analysis
  12. Fahr’s syndrome due to hypoparathyroidism revisited: A case of parkinsonism and a review of all published cases
  13. COVID-19 crisis: will online learning have negative consequences to our students?
  14. COVID‐19 and nuclear cardiology: Introducing the “forward” virtual visit
  15. Differences of apathy perfusion correlates between Alzheimer’s disease and frontotemporal dementia. A 99mTc-HMPAO SPECT study with automated Brodmann areas analysis
  16. In the era of FDG PET, is it time for brain perfusion SPECT to gain a place in Alzheimer’s disease imaging biomarkers?
  17. A second wave of COVID-19 infections should not lead to a new disruption of services in nuclear cardiology
  18. Premature CAD: Conventional Screening and Diagnostic Strategies May Not Capture the “Whole Picture”
  19. Exercise stress testing: Time to restart in nuclear cardiology?
  20. SLC2A3 rs12842 polymorphism and risk for Alzheimer’s disease
  21. Low-dose radiation cancer risk hypothesis may lead to ‘radiophobia’-driven imaging avoidance?
  22. Pet tracers for vulnerable plaque imaging
  23. Novel approaches for the management of coronary artery disease
  24. Impact of renin–angiotensin–aldosterone system polymorphisms on myocardial perfusion: Correlations with myocardial single photon emission computed tomography-derived parameters
  25. Evaluation of the Performance of 18F-Fluorothymidine Positron Emission Tomography/Computed Tomography (18F-FLT-PET/CT) in Metastatic Brain Lesions
  26. Detection of extramedullary hematopoietic tissue in a patient with beta-thalassemia major on Tc99m-sestamibi parathyroid scintigraphy
  27. Obstrucción de la vena cava superior por seminoma testicular con metástasis en el mediastino. Imagen de vías colaterales durante la gammagrafía por hemorragia intestinal con hematíes marcados con 99mTc
  28. SPECT and PET imaging in Alzheimer’s disease
  29. Radiolabeled mAbs as Molecular Imaging and/or Therapy Agents Targeting PSMA
  30. 18F-fluorothymidine PET imaging in gliomas: an update
  31. SPECT and PET in ischemic heart failure
  32. Magnetic Resonance Spectroscopy and Single-Photon Emission Computed Tomography in the Evaluation of Cerebral Tumors: A Case Report
  33. α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease
  34. Radioisotopic vs Non-Radioisotopic Methods for Myocardial Viability Identification
  35. Myocardial perfusion and left ventricular quantitative parameters obtained using gated myocardial SPECT: Comparison of three software packages
  36. Clinical Evaluation of Brain Perfusion SPECT with Brodmann Areas Mapping in Early Diagnosis of Alzheimer’s Disease
  37. Brain Perfusion SPECT with Brodmann Areas Analysis in Differentiating Frontotemporal Dementia Subtypes
  38. The Emerging Roles of Adiponectin in Female Reproductive System-Associated Disorders and Pregnancy
  39. Radiolabeling approaches of nanoparticles with99mTc
  40. Metabolism-Related Cytokine and Hormone Levels in the Serum of Patients with Myelodysplastic Syndromes
  41. Perfusion SPECT studies with mapping of Brodmann areas in differentiating Alzheimer’s disease from frontotemporal degeneration syndromes
  42. Ghrelin
  43. Molecular Nanomedicine Towards Cancer: 111In-Labeled Nanoparticles
  44. Incremental prognostic value of 99mTc-tetrofosmin early poststress pulmonary uptake. Determination of the optimal cut-off value
  45. SPECT and PET Imaging of Meningiomas
  46. Clinical Significance of Tetrofosm in Extracardiac Uptake During Myocardial Perfusion Imaging
  47. Does hybrid diagnostic imaging in cardiology have the same significance as in oncology?
  48. Sequence Variations in the FII , FV , F13A1 , FGB and PAI-1 Genes are Associated with Differences...
  49. Current and potential roles of ghrelin in clinical practice
  50. Increased fetuin A levels in Helicobacter pylori infection: a missing link between H. pylori and insulin resistance?
  51. Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome
  52. Alzheimers Disease: SPECT and PET Tracers for Beta-Amyloid Imaging
  53. Alzheimer's Disease: SPECT and PET Tracers for Beta-Amyloid Imaging
  54. Myocardial Perfusion SPECT Imaging in Patients after Percutaneous Coronary Intervention
  55. Darwinian molecular imaging in nuclear cardiology
  56. Long-term prognostic value of early poststress 99mTc-tetrofosmin lung uptake during exercise (SPECT) myocardial perfusion imaging
  57. Impact of ACE and ApoE polymorphisms on myocardial perfusion: correlation with myocardial single photon emission computed tomographic imaging
  58. On the accuracy of a mutual information algorithm for PET-MR image registration
  59. Evaluation of brain perfusion in specific Brodmann areas in Frontotemporal dementia and Alzheimer disease using automated 3-D voxel based analysis
  60. P065 Profile of metabolism-related cytokines in myelodysplastic syndromes
  61. Long-term prognostic value of heart-rate recovery after treadmill testing in patients with diabetes mellitus
  62. The Role of Nuclear Medicine in Vascular Dementia
  63. SPECT Imaging and Cerebrovascular Disease
  64. Myocardial Perfusion SPECT Imaging in Patients after Coronary Revascularization
  65. Incremental prognostic value of 99mTc-tetrofosmin myocardial SPECT after percutaneous coronary intervention
  66. Heart-rate recovery as a clinical marker of cardiovascular autonomic dysfunction in diabetic patients
  67. Drug enhancement of myocardial tracer uptake during myocardial perfusion imaging
  68. Long-Term Prognostic Value of Tc-99m Tetrofosmin Myocardial Gated-SPECT Imaging in Asymptomatic Patients After Percutaneous Coronary Intervention
  69. Radiopharmaceuticals in Neurological and Psychiatric Disorders
  70. Myocardial Perfusion SPECT Imaging in Patients after Coronary Revascularization
  71. SPECT Imaging and Cerebrovascular Disease
  72. 99mTechnetium-ciprofloxacin Scintigraphy for the Evaluation of Spinal Infections
  73. Multiple Meningiomas
  74. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography
  75. Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer
  76. Uptake and washout of 99mTcV-dimercaptosuccinic acid and 99mTc-sestamibi in the assessment of histological type and grade in breast cancer
  77. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI